Speculation about how the FDA will change under the Trump administration and the new FDA Commissioner is top-of-mind for every food safety professional today.
This webinar by Norma Skolnik will examine possible changes in the works at the FDA under the Trump administration, including what can be expected from Dr. Scott Gottlieb, new FDA Commissioner, and Tom Price, new Secretary of Health & Human Services. She will cover Trump’s regulatory agenda, his deregulation task force at federal agencies, and his proposed budgetary cuts. She will also discuss in detail Dr. Gottlieb’s intention to ease drug regulations, streamline the agency, and speed the drug approval process.
Who should attend?
At the Q&A session following the live event, ask a question and get advice unique to your situation, directly from our expert speaker.
- Will Woodlee,
- Dr. John M. Ryan, Ph.D.
- Dr. Keith Warriner,
- Justin J. Prochnow,
- Norma Skolnik,
- Ron Vail ,
Norma Skolnik has over 35 years of regulatory experience working with the pharmaceutical and dietary supplement industries. She served as Director of Regulatory Affairs for the Americas for Cadbury Adams. Prior to that, she was Director of Regulatory Affairs for the Adams Division of Pfizer and Associate Director of Regulatory Affairs for the Warner-Lambert company. She also served as Director of Regulatory Affairs for Lederle Consumer Healthcare and...
More Events By The Speaker